Weixue Si
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
-
- Vaccine Coverage and Hesitancy
Papers in
-
- Carbohydrate Chemistry and Synthesis 1
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Hanning Hu (1 shared paper)Lin Luo (1 shared paper)Jianying Huang (1 shared paper)Xinghuan Wang (1 shared paper)Xiaohong Song (1 shared paper)Tao Zhu (1 shared paper)Lihua Hou (1 shared paper)Shipo Wu (1 shared paper)
- Journals
- The Lancet Infectious Diseases (1 paper)ACS Applied Materials & Interfaces (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- China
In The Last Decade
Weixue Si
3 papers receiving 202 citations
Weixue Si's Hit Papers
Peers
Comparison fields: 5 of 48
- Infectious Diseases 136
- Health 36
- Animal Science and Zoology 25
- Immunology 37
- Pharmaceutical Science 11
Countries citing papers authored by Weixue Si
This map shows the geographic impact of Weixue Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixue Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixue Si more than expected).
Fields of papers citing papers by Weixue Si
This network shows the impact of papers produced by Weixue Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixue Si. The network helps show where Weixue Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Weixue Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Hit paper breakdown → | 2021 | 203 |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 |
About Weixue Si
Weixue Si is a scholar working on Organic Chemistry, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 3 papers that have together received 207 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (1 paper), Lung Cancer Research Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper), Carbohydrate Chemistry and Synthesis (1 paper), Virus-based gene therapy research (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Infectious Diseases (136 citations), Health (36 citations), Animal Science and Zoology (25 citations), Immunology (37 citations) and Pharmaceutical Science (11 citations). Weixue Si has collaborated with scholars based in China. Frequent co-authors include Hanning Hu, Lin Luo, Jianying Huang, Xinghuan Wang, Xiaohong Song, Tao Zhu, Lihua Hou, Shipo Wu, Jun Zhang and Jinlong Zhang. Their work appears in journals such as The Lancet Infectious Diseases, ACS Applied Materials & Interfaces and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.